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Abstract 
In situ hybridization, in situ transcription, and in 
situ polymerase chain reaction (PCR) are techniques 
used to detect DNA and RNA sequences within a cell or 
tissue structure. These three in situ methodologies 
employ the principles of recombinant DNA to form 
double-stranded hybrids of DNA-DNA, DNA-RNA, or 
RNA-RNA. The essence of in situ hybridization (ISH) 
is the hybridization of a labeled probe to a comple-
mentary target sequence, whereas in situ transcription 
(1ST) is the synthesis of complementary DNA incorpora-
ting a label directly on the target DNA or RNA within 
a cell or tissue. In the case of in situ PCR (ISPCR), it 
is the repeated in situ duplication of both the sense and 
antisense strands of DNA to increase the number of 
copies of the target sequence. ISH, 1ST, and ISPCR 
each have their advantages and disadvantages. The 
purpose of this chapter is to address in situ considera-
tions requried of these techniques, emphasizing tissue 
fixation, pre-hybridization steps, DNA probes, RNA 
probes, oligoprobes, and probe labeling. Five success-
fully used protocols are presented as examples. Any 
given nucleotide target sequence may have its own 
unique set of optimum conditions, thus requiring some 
adjustment in the hands of the user. 
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in situ polymerase chain reaction, molecular morpholo-
gy, cytochemistry. 
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Introduction 
In situ hybridization, in situ transcription, and in 
situ polymerase chain reaction (PCR) are techniques 
used to detect DNA and RNA sequences in chromo-
somes, cells or intact tissue sections. These three in situ 
methodologies employ the principles of recombinant 
DNA (rtDNA) as they are broadly defined [49), and rely 
on the powerful and widely used technique of nucleic 
acid hybridization which exploits the ability of comple-
mentary sequences in single-stranded DNAs and RNAs 
to pair with each other to form double-stranded hybrids 
of DNA-DNA, DNA-RNA, or RNA-RNA. Man-made 
sequences of nucleotide that specifically bond or hybrid-
ize to a target sequence in an A-T (or U) and C-G 
complementary fashion are called DNA or RNA probes. 
In the in situ hybridization technique, the probes are 
labeled with a radioisotope or chemically tagged for the 
detection and localization of the hybridized probes. The 
hybridized probes are then detected by either a direct or 
indirect method. In the in situ transcription technique, 
an unlabeled probe is used as a primer and labeled 
nucleotides are incorporated into the cDNA that is 
synthesized as the primer is extended on the target 
template. In the case of in situ PCR, the target sequenc-
es are bracketed by two primers and are amplified by 
making a large number of copies, and then the copies 
are detected or directly visualized. 
The essence of in situ techniques 
The essence of in situ hybridization (ISH) is the 
hybridization of a labeled probe to a complementary 
target sequence. In its simplest form, ISH is performed 
by separating the strands of double-stranded nucleic 
acids by denaturing, hybridizing a labeled probe to its 
complementary DNA or RNA in tissue sections or 
individual cells, washing away the unhybridized probe, 
and detecting the label on the bound probe. Protocols 
will be presented that will take advantage of simplicity 
and directness of ISH. The advantages and disadvantag-
es of ISH and the need for controls will be discussed. 
The essence of in situ transcription (1ST) is the 
synthesis of complementary DNA (cDNA) within a cell. 
In its simplest form, IST is performed by annealing a 
specific unlabeled primer to its complementary mRNA 
in a tissue section or individual cell, washing away the 
unhybridized primer, and synthesizing cDNA in the 
presence of reverse transcriptase and deoxynucleotide 
triphosphates (dNTPs), some of which are labeled. 
Protocols will be presented that take advantage of the 
simplicity of IST, the use of Digoxigenin (DIG)-labeled 
dUTP and an immunochemical bridge. The advantages 
and disadvantages of IST and Immunogold Silver 
Staining (IGSS) will be discussed. 
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The essence of in situ PCR (ISPCR) is repeated in 
situ transcriptions of both the sense and antisense strands 
of DNA to increase the number of copies of the target 
sequence. In its simplest form, ISPCR is performed by 
denaturing double-stranded nucleic acids to single-
strands, two primers bracketing a sequence of interest 
are hybridized to their targets, the sequence amplified 
with PCR, and the amplicons detected. The advantages 
of ISPCR and the need for controls will be discussed. 
For more detailed discussion of these techniques, readers 
are referred to the monographs and reviews published on 
the topics [14, 16, 58, 63, 75]. 
Historical background 
ISH, IST, and ISPCR, like other scientific tools and 
the new knowledge they provide, were preceded by 
other key discoveries and innovations. From our 
perspective, there were about a dozen or so historic 
milestones spanning approximately two decades which 
made molecular biology possible and the application of 
ISH, 1ST, and ISPCR to tissues and cells in situ, 
practical. The 1969 work of Gall and Pardue [24), 
demonstrating the formation and detection of RNA-DNA 
hybrid molecules in situ, were proof-of-principle find-
ings that made the ISH technique possible. In 1970, the 
discovery of RNA-dependent DNA polymerase (or 
reverse transcriptase) by two independent groups, 
Baltimore [5] and Ternin and Mizutani [88), and the 
1971 work of Kleppe et al. [51] demonstrating the 
replication of short synthetic DNA segments catalyzed 
by DNA polymerases, demonstrated the possibility of 
1ST. But it was not until Langer et al. [59) enzymatical-
ly synthesized Biotin-labeled polynucleotides, followed 
by the work of Saiki et al. in 1985 [82) that achieved in 
vitro primer-mediated amplification of genomic DNA, 
that practical 1ST was made possible. The 1ST tech-
nique was first described and applied to tissue sections 
by Tecott et al. in 1988 [87) and was confirmed and 
applied to cells in vitro by Longley et al. in 1989 [67). 
The field picked up steam with three landmark discover-
ies: i.e., the 1973 work of Cohen et al. [17) demonstrat-
ing the cloning DNA fragments into plasmid vectors, the 
1975 work of Kohler and Milstein [57] demonstrating 
the development and in vitro production of monoclonal 
antibodies, and the 1976 work of Chien et al. [15] 
discovering thermostable DNA polymerase. This was 
later followed in 1987 by Kogan et al. [56] who intro-
duced the use of thermostable DNA polymerase and 
made possible the practical use of the polymerase chain 
reaction (PCR). The introduction of liquid phase PCR 
and its automation dramatically improved the rate of 
progress for molecular biology [77]. The aforemen-
tioned milestones were essential advances for the advent 
of ISH, IST, and ISPCR, and were indirectly necessary 
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for the proof-of-principles of these in situ techniques. 
Scope of Chapter 
Many names have been given to these techniques 
encompassing a wide range of protocols, but the princi-
ples remain the same. In this chapter, we give a concise 
and comprehensive review of the principles and proce-
dures of these techniques and their major variations. As 
examples, certain protocols that have been tested by the 
authors are included at the end of this chapter. 
In situ Conditions 
General considerations 
In vivo nucleotide sequences anneal and separate 
with a high degree of precision. In vitro their behavior 
also follows certain general rules. The factors that 
affect their behavior the most include temperature, salt 
concentration, length of the probes, percentage of C-G 
content, pH and concentrations of certain chemicals such 
as formamide. Changing the temperature or pH are the 
most commonly used methods to manipulate the anneal-
ing and denaturation of DNA or RNA [16). 
Fixation 
The most commonly used fixatives for in situ 
hybridization have been aldehyde-based fixatives such as 
10% formalin or 4% paraformaldehyde [14). The 
aldehyde fixatives cross link proteins, or proteins and 
nucleotides, and effectively preserve the nucleotide 
sequence. Fixatives with picric acid such as Bouin's 
fixative or heavy metals such as Zenker's solution 
should be avoided as damage of target nucleotide 
sequences may occur [27). Fixation from three hours to 
overnight appears to be an acceptable range depending 
on the size and nature of the tissue and the strength of 
the fixation. Frozen sections can also be used. 
Pre-hybridization steps 
The aldehyde-fixed samples need to be digested to 
expose the targets, yet this digestion should be optimized 
to also preserve the morphology and retain the target 
sequences after hybridization. Proteinase K, trypsin, 
pronase and other proteases have all been used success-
fully. The digested sections should be washed thorough-
ly to remove or inactivate all the enzymes. A pre-
hybridization step is recommended which should elimi-
nate or reduce the background nonspecific reactions. 
This usually consists of a cocktail of the hybridization 
solution without the specific probe to exhaust possible 
nonspecific bonding sites prior to incubation of the 
specific probes. Additional pretreatment using 
levamisol, normal rabbit serum, etc. can also be per-
formed to prevent the subsequent detection step causing 
any background. The samples are then equilibrated in 
a solution that is close to the hybridization condition [37) 
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and proceed with the hybridization steps. We have also 
found that it may be beneficial to let the samples dry 
after the equilibrate washing and applying the hybridiza-
tion cocktail directly on the dry samples. When nonspe-
cific background staining is controlled, this usually gives 
stronger signals, presumably because of a better penetra-
tion of the probes to the tissue sample and a more 
controlled concentration of the salts in the immediate 
environment of the hybridization reaction. 
DNA probes 
The key in probe design and selection is that the 
probe sequence has to be specific to the target and not 
complementary to any other sequence. Double-stranded 
DNA probes were the initial approach developed for in 
situ hybridization because of their relative stability. 
They can, however, be destroyed by DNase which 
requires magnesium to function and can be inhibited by 
EDTA [80). They are usually labeled by nick transla-
tion or random primer extension. These probes can be 
as long as a few thousand nucleotides or as short as 1 or 
2 dozen nucleotides [80). Double-stranded probes must 
be denatured before hybridization, which is generally 
achieved by increasing the temperature. The drawback 
of double-stranded probes is that the two strands tend to 
re-anneal to themselves during hybridization, thereby 
decreasing the detecting efficiency. Single-stranded 
DNA probes can also be produced by using the 13M 
cloning vectors [42, 72) and PCR [68), overcoming the 
disadvantage of probe re-annealing. Thus, they are 
more efficient at hybridizing to their targets than double-
stranded probes [78). 
RNA probes 
A riboprobe is a single-stranded RNA probe pro-
duced by cloning man-made vectors containing promot-
ers and an insert of cDNA fragment of interest at a 
known orientation [ 4 7, 71, 85). The recombinant 
plasmid vectors can be grown and amplified in appropri-
ate bacterial hosts, whereby the inserted cDNA grows in 
quantity. The inserted sequences are then transcribed 
with RNA polymerase into RNA probes. Radioisotope 
or other labeling molecules can be incorporated during 
transcription. By reversing the orientation of the 
inserted cDNA, both anti-sense and sense RNA probes 
can be produced. A "sense" probe refers to a sequence 
equivalent to the target mRNA and an "antisense" probe 
is complementary to the sequence and is used to hybrid-
ize with the target. Riboprobes are superior to DNA 
probes in that they are single-stranded and do not 
reanneal to themselves, resulting in a more efficient 
target detection [3, 18, 64, 80). When hybridized to 
mRNA, it is more stable than DNA-RNA hybridization 
and can stand stringent hybridization conditions and 
washing [44). Following hybridization, it is possible to 
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destroy the unhybridized single-stranded probes with 
RNase, further reducing the background. A large 
amount of the same kind of probe can be generated. 
However, the preparation of riboprobes requires the 
availability of the appropriate cDNA, considerable 
experience with molecular biological skills to prepare 
and propagate the plasmids and transcripts, and an 
RNase-free environment for probe preparation and 
handling. It is more specific than the shorter oligo-
probes. A good riboprobe can bind its complementary 
mRNA more tightly than the shorter oligoprobes allow-
ing for more stringent washing, which can lead to lower 
backgrounds and a more specific detection of the target. 
Oligoprobes 
Oligoprobes (or oligoprimers) are small single-
stranded probes that possess many advantages [ 43]. The 
simplicity in manufacturing those probes make them an 
easy choice for in situ hybridization. If the target 
sequence is known, oligoprobes can be synthesized with 
a DNA synthesizer or ordered from a molecular biologic 
reagent company at a reasonable cost. The length of an 
oligoprobe should be about 14-50 bases [80]. The 
sequence has to be unique to the target of interest so that 
unwanted hybridization will be minimized. The percent 
of G and C content is also important as this will affect 
the thermostability of the hybrid or the background 
labeling. Optimal conditions for individual probes and 
targets should be established empirically, particularly for 
oligoprobes, as the window for optimal hybridization is 
narrower than for longer probes. 
Probe labeling 
A variety of molecules have been used to label 
probes. Radioisotope labeling remains the most sensi-
tive approach. 35S and 33P have been a good compro-
mise for probe labeling as they do not require too long 
an exposure time for autoradiography and give relatively 
high resolution. These labeling methods are widely used 
because of their sensitivity and reliability [ 47, 64]. 
Non-radioisotope labeling has become increasingly 
popular and, with refinement of the technique, more 
sensitive [29, 58, 76]. These methods avoid the hazard-
ous radioisotope handling and disposal, shorten the 
experimental protocol, and yield high resolution results 
that can be combined with other techniques such as 
immunohistochemistry. It is also suitable for in situ 
hybridization at the electron microscopic level when 
used in combination with immunogold labels. Common-
ly used labeling molecules include biotin, digoxigenin, 
alkaline phosphatase, hapten and fluorescein. Biotin 
enjoys the popularity because of the availability of a 
wide variety of detection kits. Digoxigenin is a plant 
molecule that can be recognized by specific antibodies, 
providing added specificity and sensitivity due to re-
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duced nonspecific binding, and is preferred by many 
investigators. Fluorescein can yield very high signal-to-
noise ratios and detecting sensitivities, and therefore has 
been widely used in chromosomal labeling, and often 
goes by the acronym FISH (Fluorescence In Situ Hy-
bridization) [48, 69, 93]. 
Optimizing in situ Conditions 
The search for optimal condition for hybridization 
is one of the key issues for successful experiments. It 
is important to determine the melting temperature at 
which 50 % of the double-stranded sequences are dena-
tured. Equations are available for different factors that 
govern the relationship between the two complementary 
sequences in the denaturing and reannealing processes. 
Generally for ideal hybridization, the reannealing 
temperature should be set to 20-25°C lower than the 
melting temperature to generate a stable hybridization 
product. To ensure specificity for shorter probes, the 
hybridization temperature may be adjusted at 12-17°C 
below the melting point. The optimal hybridization 
temperature should be established empirically in addition 
to being predicted from the formulas. A temperature 
range of 37-42°C is a good starting point for the hybrid-
ization step. This is derived from inclusion of 50 % 
formamide in the hybridization solution which competes 
with bases for the formation of hydrogen bonds and 
thus lowers the temperature requirement. For a DNA 
sequence with 50 % C-G contents in 0.4 M sodium 
chloride containing 50 % formamide, the melting temper-
ature is about 54.5°C, and the hybridization temperature 
is adjusted to 37-42°C. The concentration of a probe is 
also important. It is usually used at around 300 ng/m1 
with a range of 200-1500 ng/m1 depending on the size of 
the probes. The hybridization kinetic is also affected by 
salt concentrations. At concentrations below 1.5 M, the 
higher the salt concentration, the higher the rate of 
hybridi:z.ation. Polymers of high molecular weight, such 
as dextran sulfate and polyethylene glycol, are often 
added at a concentration of about 10% (v/w). Those 
molecules can create a networking phenomenon, taking 
up sufficient space in the solution to artificially increase 
the probe concentration and thus the hybridi:z.ation rate 
by about tenfold without creating any noticeable side 
effects [1,2]. The washing solution should be designed 
to contain the appropriate salt content that will wash 
away unbound probes and probes in less stable, mis-
matched hybrids, and leave the perfectly-matched 
hybrids intact. To set up an in situ hybridization 
protocol for a new target, the best approach is to follow 
previously established procedures and then adjust the 
various conditions, one at a time, starting from the 
probe design, hybridi:z.ation solution and incubation 
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temperature. Changing probe design is often the most 
effective measure to make in situ hybridization work. 
In situ Hybridization 
Technically in situ hybridization is a well established 
method. The protocols are fairly straight forward. 
When the right probes are selected and the target 
sequences are preserved and accessible, the properly 
executed hybridization procedure should lead to clear 
and well defined signals with low background. The 
window of opportunity for achieving optimal reaction is 
fairly broad. Certain small mishaps in performing the 
technique would not lead to unusable results. 
Advantages of ISH 
One of the advantages of in situ hybridization, in 
comparison to in situ transcription and in situ PCR, is 
that the probes are hybridired to the target DNA or 
RNA sequences directly without target manipulation or 
amplification. What are amplified in the in situ hybrid-
ization protocols are the labeling molecules not the 
targets themselves. Therefore, there is little problem of 
product diffusion or amplicon back diffusion, sometimes 
a formidable problem for in situ PCR. In addition, 
when the signal amplification steps are constant, the 
amount of reporting signals are approximately propor-
tional to that of the target, thus allowing semiquantitative 
assessment of the target DNA or RNA. When evaluated 
jointly with the results obtained with immunocytochemis-
try, this semiquantitative information can lead to mean-
ingful interpretations of the cellular components under 
study. For example, they may indicate the balance or 
imbalance of the expression of a particular gene and the 
production of the coded protein. When the distributions 
and relative quantities of the gene expression and its 
protein are different, certain cellular events could be 
indicated [29, 86, 88]. 
Disadvantages of ISH 
The disadvantage of in situ hybridization is that it is 
not as sensitive as in situ PCR, or in situ transcription. 
Nevertheless, with the newly reported, more powerful 
signal enhancement techniques such as the nanogold-
silver immunostaining and computer enhanced fluores-
cence in situ hybridization, the detecting sensitivity of in 
situ hybridization has been improved markedly [35, 69, 
78]. 
In situ Transcription 
1ST is initiated by the hybridization of a primer 
(usually a specific oligonucleotide) to target mRNA in a 
tissue section or cell preparation on a glass slide as is 
done in conventional ISH [18, 38, 50, 62, 63, 65, 66]. 
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Transcription of the target mRNA is achieved by adding 
reverse transcriptase and labeled nucleotides which allow 
the synthesis of a labeled complementary DNA (cDNA). 
Since the synthesired cDNA remains associated with its 
mRNA template as a cDNA-mRNA hybrid, anatomical 
distribution and cellular localization are preserved, thus, 
it is one of the main advantages of 1ST. 
In the original works [67, 87), radio labels were 
used and the localization of the labeled cDNA was 
detected by autoradiography. Many non-radioactive 
detection systems have been developed for ISH and can 
be applied to 1ST, i.e., fluorochrome-labeled dNTPs in 
fluorescence methods [6, 7, 52, 65, 66, 89, 93), biotin-
labeled [26, 39, 50, 53, 55, 59, 65, 73, 74] or digoxi-
genin-labeled [19, 20, 36, 39, 79, 91, 92] dNTPs in 
immunochemical detection methods. 
One of the first applications of the 1ST technique 
was to the localization of proopinmelanocortin (POMC) 
mRNA on fresh-frozen paraformaldehyde-fixed sections 
of rat pituitary using reverse transcriptase and radio-
labeled 3H-dCTP in the cDNA elongation process 
followed by autoradiography [87]. In another early 
study, 1ST was applied to localired alpha-2 domain of 
CD la mRN A using an oligonucleotide primer specific to 
the target mRNA, incorporating 35S-dCTP into cDNA 
followed by autoradiography [67]. 1ST has also been 
used to investigate the temporal expression of mRNAs 
in developing embryos [22, 23). One of the most 
intriguing uses of 1ST was in the analysis of gene 
expression in live cells where mRNA in single live 
neurons in vitro was injected with primer, dNTPs, and 
reverse transcriptase via whole cell patch electrode. The 
contents of the cell was then harvested by suction back 
into the electrode, the electrode incubated in vitro where 
the cDNA is first synthesired by 1ST followed by 
replication of cDNA to many copies of amplified RNA 
(aRNA) [90]. The aRNA was assessed by Southern and 
Northern blot analysis. More recently 1ST has been 
used to localize -y-GTP mRNA in paraffin section from 
rat kidney [91] and from cell cultures of rat brain micro-
vessels [92]. 
One technique closely related to 1ST for mRNA is 
termed, PRimed in situ labeling (PRINS), which was 
first used by a Danish group to localize chromosomal 
DNA [52-55], and was later confirmed by a group in 
Scotland [26, 73). For clarity, the PRINS technique 
applied to DNA is referred to as PRINS-DNA. The 
PRINS-DNA procedure uses unlabeled DNA probes or 
oligonucleotides as the primer, and DNA polymerase 
(Kienow or Taq-1) and biotin or digoxigenin labeled 
dNTPs to synthesize labeled DNA in situ. The site of 
synthesis was detected by immunocytochemistry using 
fluorochromes as reporter molecules. A variation of 
PRINS-DNA can be used in the detection of mRNA [54, 
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74], and when applied to mRNA it is referred to as 
PRINS-mRNA. PRINS-mRNA is virtually the same as 
IST in that it uses an unlabeled primer complementary 
to a specific mRNA sequence, and reverse transcriptase 
and labeled dNTPs to synthesize a labeled cDNA. Thus 
all comments made about IST should also apply to 
PRINS-mRNA. 
Advantages of 1ST 
Since chain elongation is independent of the length 
of the primer, oligonucleotide primers induce as much 
(if not more) labeling of the target mRNA than a much 
longer pre-labeled probe, thus increasing the sensitivity 
of the method. Another advantage of IST is its applica-
tion to the detection of minor sequence variations in 
RNA by the proper selection of the sequence; thus, the 
position of the primer can control whether or not there 
will be chain elongation. The application of IST to the 
detection of minor sequence variations should be superi-
or to ISH in that it is well known that the last few 
nucleotides of the primer are crucial to the initiation of 
chain elongation [10]. A significant technical advantage 
of the method is that the probe (primer) is unlabeled and 
labeling occurs only secondarily to specific hybridiza-
tion, and the unincorporated labeled nucleotide can be 
washed away easier, which results in a lower back-
ground. In addition, fewer procedural steps allow for a 
shorter cumulative incubation time resulting in less 
degradation in the tissue morphology which often 
accompanies ISH or ISPCR. Another advantage of the 
milder conditions of IST is that it allows for the detected 
mRNA in cell suspension intended for flow cytometry 
without clumping and disintegration of cells [ 4]. 
Disadvantages of 1ST 
The main disadvantage of IST is that it requires a 
high copy number of target mRNA (or DNA). If the 
copy number is low, ISH may be the technique ~f 
choice. If the copy number is very low, then ISPCR 1s 
the technique of choice, and has been shown to be able 
to detect a single copy. See ISPCR below. 
In situ PCR 
In situ PCR combines the DNA amplifying power 
of liquid phase PCR with the localizing capability of in 
situ hybridization [28, 63]. First, it amplifies minute 
quantities of DNA or RNA fragments to millions or 
billions of identical copies at the site of the original 
template and then detects or visualizes the amplified 
signal in situ. This technique fills a technical gap and 
allows detection of low copy numbers of nucleotide 
sequences against the background of tissue structure, 
even detecting a single copy of DNA or RNA per cell 
[78]. ISPCR is particularly important in detecting latent 
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virus infections and studying the pathogenesis of many 
viral and oncogenic diseases [28, 78]. 
In situ PCR can be performed in several different 
ways. It can directly incorporate labeling molecules into 
amplified products by using labeled primers or labeled 
free nucleotides in PCR. This way, all amplified 
sequences have the labeling molecule built into them for 
subsequent detection. The amplified sequence can also 
be detected by employing in situ hybridization with a 
labeled probe complementary to the amplified target. 
RNA can be reverse transcribed into cDNA and then 
amplified and detected. Several in situ PCR machine 
models are available on the market. Each has its 
advantages and limitations. 
It is well recognized that the key steps in in situ 
PCR include tissue preparation, pretreatment, primer 
and probe design, washing and detection. However, the 
prevention of amplified product diffusion is perhaps the 
most important consideration in designing any in situ 
PCR protocol. This technique is relatively new and 
technically challenging. False positivity and negativity 
can occur easily and should be carefully checked with a 
number of control experiments, including positive and 
negative tissue samples, and omission of primer, probe 
or other key components, one at a time, in the amplifi-
cation or detection mixtures. The ISPCR results should 
be compared with results obtained by liquid phase PCR 
using the same primers and probes to detect the same 
sequences on DNA or RNA extracts from the same 
tissue samples. 
Advantages of ISPCR 
The most obvious advantage of in situ PCR is, of 
course, its very high detecting sensitivity while retaining 
tissue morphology so that minute quantities of DNA or 
RNA can be visualized and correlated to the surrounding 
morphology. It was reported that it can detect down to 
a single copy of a DNA or RNA sequence in intact cells 
or on tissue sections. This makes it a very valuable tool 
for many purposes, especially the detection of early or 
latent viral infections or early genetic changes in onco-
genesis. All these can be achieved with commonly used 
enzyme labeling methods and viewed with a transmitting 
light microscope. The detecting sensitivity of conven-
tional in situ hybridization is not entirely clear, but is 
believed to need at least 20 copies for detecting and thus 
leaves a technical gap where in situ PCR finds most of 
its applications. A second advantage is, in theory, in 
situ PCR can be combined with other methods to 
demonstrate two targets simultaneously on the same 
tissue preparation. It can also be performed at the 
electron microscopic level, although the preliminary 
reports in this regard (mostly in abstract forms) showed 
very poor ultrastructure preservation. A third advantage, 
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again in theory, is that direct in situ PCR can detect 
DNA or RNA targets without knowing the entire 
sequence by using a pair of primers flanking the two 
ends of the target. Overall, in situ PCR has a high 
detecting sensitivity that has made in situ PCR so 
popular. 
Disadvantages of ISPCR 
In comparison with in situ hybridization and other 
highly sensitive methods, in situ PCR has a number of 
disadvantages. First, it is technically challenging to set 
up reliable in situ PCR and, once set up, the technique 
is often not very stable. This is due primarily to the 
large number of critical steps in the protocol. These 
include adequate enzyme digestion, efficient amplifica-
tion, prevention of amplicon diffusion, and reduction of 
background. It often takes longer and needs more 
controls to establish reliable in situ PCR protocols. The 
second disadvantage is that the tissue morphology is less 
than ideal. Because of digestion and, in particular, the 
harsh treatment by the thermal cycling, the morphology 
of the samples, although still recognizable, is often 
distorted and damaged. The third disadvantage is that 
the protocol of in situ PCR requires specially designed 
machines which makes it more expensive and less 
convenient to perform. Fourth, because of the very high 
detecting sensitivity, the less than desirable morphology 
and the potential problems associated with amplicon 
diffusion and inadequate digestion or washing, the 
results could be difficult to interpret. Extensive controls 
are sometimes called for and this might make the 
experiment lengthy and less manageable. Strict internal 
and external controls are needed for in situ PCR; 
however, optimal control kits are not currently available 
for this technique. 
It should be mentioned that although in situ PCR is 
a very powerful and attractive technique, it is not the 
only one for detecting low copy number of nucleotide 
fragments. Other procedures such as FISH, nanogold-
silver method, 3-SR technique, radioisotope labeled in 
situ hybridization, and autoradiography, etc., can also 
detect those sequences without some of the drawbacks of 
in situ PCR. Each of the methods has it strengths and 
weaknesses and should be considered before committing 
a given in situ PCR protocol. 
Controls 
As for immunohistochemistry, it is extremely 
important to perform adequate controls to verify the 
specificity of in situ hybridization [14, 16, 58, 63, 75]. 
For single-stranded probes, a common approach is to 
use a sense instead of antisense probe as a negative 
control and follow the exact same protocol. However, 
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it has been reported [44), although rarely noted in the 
literature, that a small number of antisense sequences 
may be produced by the target cells, possibly by a 
mechanism of transcription regulation. Therefore, a 
sense probe may result in a reduced but still specific and 
positive labeling. We have observed this phenomenon 
and learned to interpret the sense probe results with 
caution [29). Using an unrelated probe of the same 
length and C + G content is the best way to get around 
this problem. Positive controls may include a tissue 
preparation with a known quantity and distribution of the 
target sequence. Negative controls may include a piece 
of tissue that is known not to contain the target se-
quence. This can be created artificially by treating the 
tissue sections with RNase or DNase to destroy the 
target sequences. However, this needs to be performed 
carefully and followed by extensive washing. Any trace 
residue of the enzyme that finds its way into the real 
experiments may destroy the target or probe. Additional 
controls may include the omission of each of the key 
elements in the incubation cocktails. This is often 
effective in checking the ingredients that cause the false 
positivity or give high background. It is always advis-
able to perform Southern or Northern blot analysis on 
DNA or RNA extracts of the same target tissue side-by-
side with in situ hybridization to verify the presence and 
quantity of the target sequences. The specificity of the 
visualization methods also needs to be checked including 
replacement of each of the key elements, particularly the 
primary antibody or the first linking reagent to the 
probe. Only after the key controls give the expected 
results can the observations with in situ hybridization be 
validated. 
It should be noted that new techniques are emerging 
that can detect low copy numbers of DNA and RNA 
without going through the elaborate in situ amplification 
steps. The reporting signals can be amplified instead of, 
or in addition to, the amplification of the target sequenc-
es themselves. 
EM in situ hybridiution 
In situ hybridization has been applied at the electron 
microscopical levels using electron-opaque labels [25]. 
The attempts of applying in situ PCR at the EM level 
have not been very successful because of the deteriora-
tion of the ultrastructure caused by the many PCR 
cycles, although signals have been reported to be 
visualized under the electron microscope. 
Both preembedding and postembedding in situ 
hybridization can be performed on electron microscopic 
grids. The procedure is similar to that for the light 
microscope except that the protocols are adjusted to the 
EM conditions with much gentler digestion and washing. 
Colloidal gold remains to be the best labeling method at 
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the electron microscope level. A double labeling with 2 
differently sized gold particles can be performed on the 
same grid to demonstrate the RNA or DNA and its 
corresponding protein simultaneously, greatly facilitating 
the morphological elucidation of the subcellular regulato-
ry mechanism of a particular gene and its product [25]. 
Technically, EM in situ hybridization is quite 
challenging. The tissue samples are very delicate and 
the optimal balance of the many treatments, washings 
and reactions need to be established empirically for each 
target sequence in its host tissue. For detailed protocols, 
readers are referred to a monograph on this topic edited 
by Morel [75]. 
Protocols 
Recommended protocols of in situ hybridization 
The following protocols are selected from many 
published procedures. They have been tested in our 
own laboratories and found to be reliable and reproduc-
ible. The first is for RNA-RNA detection using ribo-
probe to detect mRNA. It has been successfully used to 
detect c-myc, N-myc and L-myc gene expression in 
small cell Jung cancers [31] and atrial natriuretic peptide 
gene expression in the heart [30, 32]. The second 
protocol uses oligoprobe that was labeled with FITC and 
detected with a specific antibody to FITC. We used this 
protocol to detect peptide mRN A including ANP, 
neuropeptide Y (NPY), insulin and glucagon. These 
protocols can be adapted to different purposes. They 
should be adjusted individually with particular probes, 
targets and tissues. The protocols rarely give optimal 
results by just copying and switching from one probe or 
target to another. Controls should always be performed 
with the experiments to assist in trouble-shooting and 
result interpretation. There is inconsistency in tissue 
preparation, digestion, pretreatment, and detection 
among the protocols. This was due to the fact that they 
were developed in different laboratories by different 
individuals. They have all worked well for their particu-
lar applications at the time of the studies. 
Common materials and equipment. The equip-
ment needed are incubation oven, adjustable precision 
pipettes, glassware, glass slides, coverslips, etc. The 
reagents and solutions needed are xylene, alcohol, 
dextran sulfate, saline sodium citrate (SSC) (20x, 5x, 
2x, lx), EDTA (1 mM), Tris-buffered saline (TBS) (50 
mM Tris/RC!, 150 mM NaCl pH 7.6), alkaline phos-
phate substrate buffer (100 mM Tris/RC!, 50 mM 
MgCJ2, 100 mM NaCl pH 9.0), formamide (HCONHJ, 
Diethyl Pyrocarbonate (DEPC; Sigma, St. Louis, MO). 
Protocol #1: in situ hybridization using biotin-
labeled riboprobes on tissue sections. 
1. Prepare tissue sections by dewaxing, rehydra-
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tion, washing in DEPC-treated water, etc. 
2. Digest tissue with Proteinase K, 5-30 µglml at 
37°C for 10-30 min in humid chamber. 
3. Wash in DEPC-treated water for 3x2 min. 
4. Deactivate Proteinase K at 70-75°C for 1 mm 
(optional) wash in double distilled water 5 mins. 
5. Prepare prehybridization solution (for 1 ml): 
50% Dextran sulfate 250 µI 
20xSSC 149 µI 
EDTA (1 mM) 120 µI 
Herring Sperm DNA 33 µI 
DEPC-treated water 448 µI 
6. Apply prehybridization solution to tissue section 
and incubate at 42°C for 30 min. 
7. Prepare hybridization solution with biotinylated 
probe. 
Hybridization solution (H.S.) (for 1 ml): 
50 % Dextran sulfate 250 µI 
EDTA (i mM) 120 µI 
20xSSC 100 µI 
Formamide 450 µI 
Herring Sperm DNA 33 µI 
DEPC-treated water 47 µI 
Mix well and add probe. Probe final concen-
tration: 0.2 - 1.5 ng/ µI. 
8. Apply hybridization solution. 
9. Incubate 3 hours to overnight at 42°C in humid 
chamber. 
10. Wash in 5x SSC for 5 min. 
11. Wash in 2x SSC for 5 min. 
12. Proceed to detection with a biotin detection kit 
with sufficient background blockage. 
13. Wash in distilled water (2x5 min). 
14. Counterstain and mount. 
Notes to Protocol #1 
J. Radioisotope or digoxigenin-labeled in situ 
hybridization can be more sensitive than biotin-labeled 
in situ hybridization. 
2. The probe in the hybridization solution (step 8) 
can be heated to 95°C for 5 mins before being applied 
to the tissue section to eliminate any self-annealing or 
secondary structure formation of the probes. 
3. Up to step JO, the procedure should be performed 
in a RNase-free manner. 
4. The hybridization mixture can be applied on 
dehydrated dry sections or on wet sections. If the latter, 
there should be as little liquid remaining 011 the slides as 
possible to avoid diluting the concentrations of the 
ingredients in the hybridization solution. 
5. For hybridization solution of less than 40 µl per 
tissue section, a coverslip can be applied and sealed at 
the hybridization step (step 9) to prevent evaporation. 
6. RNase may be used in post hybridization treat-
ment to remove single-stranded probes, thereby reducing 
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background. This can be applied at 100 µ,glml RNase A 
and 1 unitlµ,l RNase T1 for 30 mins at 37°C. 
7. Counterstain should not mask or overshadow the 
specific labeling. 
Protocol #2: in situ hybridization using FITC-
Labeled oligoprobes on tissue sections. 
1. Prepare tissue section by dewaxing, rehydration, 
washing in DEPC-treated water, etc. 
2. Digest tissue sections with Proteinase K at 5-30 
µ,g/ml in 0.05 M Tris/HCI buffer pH 7.6 made with 
DEPC-treated water, and incubate for 10-30 min at 
37°c. 
3. Immerse in DEPC-treated, double-distilled water 
for 3 X 2 min. 
4. Dehydrate in increasing grades of ethanol. 
5. Air dry for 2 min. 
6. Prepare hybridization solution with FITC-labeled 
probe. 
Hybridization solution 
30 % Formamide 
10 % Dextran Sulfate 
0.6 M NaCl 
Mix well and add probe. Probe concentration: 
0.2-1.5 ng/µ,l, optimized for probe and 
tissue sample selected. 
7. Apply hybridization solution and coverslip. 
8. Incubate 3 hours at 42°C in humid chamber. 
9. Wash slides in TBS containing 0.1 % Triton-X-
100 for 3 x 3 min. Allow coverslips to drain off in the 
washing solution - Do not touch coverslips to remove. 
Dipping may be required to remove any remaining 
coverslips. 
10. Place slides on incubation tray and cover 
sections with 100 µ,I of TBS, containing 3 % bovine 
serum albumin, 0.1 % Triton-X-100, 20% normal rabbit 
serum. Incubate for 10 min. 
11. Tip off the blocking solution and add rabbit Fab 
anti FITC conjugated to alkaline phosphatase diluted 
1: 100 - 1: 200 in TBS containing 3 % bovine serum 
albumin and 0.1 % Triton-X-100. Incubate for 30 min -
3 hours at 20°C. 
12. Wash slides in TBS for 2 x 3 min. 
13. Wash slides in alkaline phosphatase substrate 
buffer pH 9.0 for 5 min. 
14. Place slides in humid chamber and demonstrate 
alkaline phosphatase activity by covering sections with 
the following solution (for 200 µ,I): 
80 µ,I 5-Bromo-4-chloro-3-indolylphosphate 
(BCIP) - 50 mg/ml in dimethyl formamide 
80 µ,I Nitro blue tetrazolium (NBT) - 75 mg/ml 
in 70 % dimethyl formamide 
10 µ,I 1 M levamisole 
10 ml alkaline phosphatase substrate buffer 
Color development may take from 1 hour to over-
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night. 
15. Wash in running water for 5 min. 
16. Counterstain and coverslip. 
Notes to Protocol #2 
1. In step #2, the enzyme activity can be stopped by 
optionally heating to 70°C for 1 min. Generelly the 
activity is stopped by dilution in the subsequent 
washings. 
2. Up to step 9, the procedure should be performed 
in a RNase-Jree manner. 
3. All the other notes described in Protocol #1 also 
apply to Protocol #2. 
Recommended protocols of in situ transcription 
Animals perfuse-fixed with 3 % paraformaldehyde 
and 0.5 % glutaraldehyde in O. lM PBS (pbosphae 
buffered saline), and the tissue embedded in paraffin by 
standard procedures. Under RN Ase free conditions, 25-
nt oligonucleotide probes complementary to target 
mRNA were hybridized 5 µ,m tissue sections, overnight. 
The primed mRNA was then transcribed in situ by 
incubation with a mixture of nucleotide precursors 
containing DIG-labeled dUTP, and AMV (Avian Myelo-
blastosis Virus) reverse transcriptase. After washing the 
in situ transcribed sections, the incorporated DIG was 
bridged with sheep anti-DIG IgG, and detected with 
10nm gold conjugated rabbit anti-sheep IgG followed by 
silver enhancement. Controls consisted of the omission 
of the oligonucleotide probes, or the substitution of 
unrelated 25-nt oligonucleotides in the hybridization 
step. 
1ST has been applied to tissue, perfuse-fixed, 
paraffin-embedded, and handled to permit 1ST, immuno-
cytochemistry, and enzymecytochemistry on sections all 
from the same paraffin block. This bas been illustrated 
in detail by De Bault and Wang [19) using -y-Glutamyl 
Transpeptidase (-y-GTP) in rat kidney to demonstrate the 
localization of -y-GTP enzyme activity, -y-GTP protein, 
and -y-GTP mRNA. 
Common materials and equipment: The equip-
ment needed is: incubation oven, hot plate, ice bucket, 
adjustable precision pipettes, glassware, glass slides, 
coverslips, etc. The reagents and solutions needed are 
xylene, alcohol, sucrose, bovine serum albumin (BSA), 
dithiotheitol (DTT), gum arabic, triton X-100, MgCl 2, 
KC!, citric acid, sodium citrate, SSC (20x, 5x, 2x, lx), 
EDTA (1 mM), TBS (50 mM Tris/HCI, 150 mM NaCl 
pH 7.6), RNase inhibitor, Formamide (HCONHz), 
DEPC, silver lactate or silver acetate, ice, etc. 
Protocol #3: In situ transcription using unlabeled 
oligoprimers and DIG-labeled dUTP on tissue sec-
tions. 
1. Tissue was fixed in 3 % paraformaldehyde + 
0.5 % glutaraldehyde + 2.5 % sucrose in 0.1 M PBS, pH 
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7.4, followed by standard paraffin embedding. 
2. Tissue sections were dewaxed, rehydrated in a 
graded ethanol series, and washed with 2xSSC (2xSSC 
solution consists of 0.15 M NaCl, 0.015 M sodium 
citrate, and adjusted to pH 7.0 with lN HCI). DEPC-
treated water was used to make all solutions and buffers. 
3. Each slide is incubated with 20 1-'l of ISH 
mixture containing oligonucleotide primer(s) (covered 
with a glass coverslip) at 42°C overnight, followed by 
30 min incubation at room temperature. The final 
mixture contained: 
50 % Formamide 
4xSSC 
0.02 % bovine serum albumin (BSA) 
5 mM DTT 
0.6U RNase Inhibitor/1-'l 
101-'M Oligonucleotide (see notes #5 and #6 
below for ISH solution) 
4. Wash 2 times with 2xSSC and 2 times with 
0.5xSSC, 15 min each at room temperature. 
5. Hold slides in 0.5xSSC for 2 hr before proceed-
ing with 1ST. 
6. Each slide was incubated with 15 1-'l of 1ST 
mixture containing DIG-labeled dUTP (covered with a 
glass coverslip) at 37°C for 60 min followed by 45°C 
for 10 min. The final mixture contained: 
50 mM Tris-HCl, pH 7.4 
6 mM MgCl 2 
40 mM KC! 
5 mM DTT 
0.02% BSA 
0.1 mM DIG-DNA Labeling Mixture 
0.6U RNase Inhibitor/1-'l 
1 U AMV Reverse Transcriptase/ 1-'l (see note #7 
below for 1ST Solution 
7. Wash 2 times with 2xSSC 30 min each at room 
temperature. 
8. Wash 2 times with 0.05xSSC 1 hr each at 35°C. 
9. Wash 3 times with 0.05 M TBS pH 7.4 contain-
ing 0.25 % Triton X-100 10 min each at room tempera-
ture. 
10. Slides were pre-incubated in 1 % BSA in 0.05 M 
TBS for 15 min at room temperature. 
11. Slides were incubated with 50 !,'I of 1 ° antibody 
mixture at +4 °C overnight, followed by 1 hour incuba-
tion at room temperature. The final mixture contained 
Sheep Anti-Digoxigenin antibody diluted 1:50 in 1 % 
BSA in 0.05 M TBS. 
12. Wash 3 times with 0.05 M TBS 10 min each 
followed by wash with 0.02 M TBS pH 8.2 containing 
0.25% Triton X-100 for 10 min at room temperature. 
13. Incubate in 1 % BSA in 0.02 M TBS pH 8.2 for 
15 min at room temperature. 
14. Incubate with 50 1-'l of 2° antibody mixture for 
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1 hr at room temperature. The final mixture contained 
10nm gold conjugated Rabbit Anti-Sheep IgG diluted 
1:10 in 1 % BSA in 0.02 M TBS. 
15. Wash once with 1 % BSA in 0.02 M TBS, pH 
8.2 for 10 min, followed by 3 washes of 0.05 M TBS 
10 min each. 
16. Wash with distilled water. 
17. Incubate in Silver Enhancement mixture for 
about 20 min at 22°C. The final mixture contained [34, 
40]: 
5.5 mM silver lactate or silver acetate 
77 mM hydroquinon 
120 mM citric acid 
80 mM sodium citrate 
10% gum arabic (see note #10 below for 
Silver Enhancement Solution) 
18. Wash with distilled water 5 times 2 min each. 
19. Counter stain lightly with hematoxylin and eosin 
(H&E) (optional). 
20. Mount in Permount® and coverslip. 
Notes to Protocol #3: 
1. All reagents used and steps in the perfusion and 
fuation procedure were perfonned at +4°C, unless 
otherwise stated [45, 61]. 
2. In the standard paraffin embedding, infiltration 
was by machine processing and included 2 changes of 
95% Ethanol for 20 min each, 3 changes of 100% 
ethanol for 15, 20, and 30 min respectively, 2 changes 
of Xylene for 20 and 30 min respectively, all at 40°C, 
and 2 changes of paraffin for 45 min each at 57°C. The 
tissue is embedded in flat molds [70, 83}. Completion of 
the entire embedding process 011 the same day that the 
perfusionfuation is performed is important in maintain-
ing maximum antigenicity and mRNA reactivity. 
3. 5 1-'m paraffin sections were floated on a 0.1 % 
DEPC-treated water bath at 42 °C, and picked up on 
silanized slides [81}. It is important to perfonn the in 
situ transcription and immunogold-silver staining or 
other detecting procedures immediately after cutting; cut 
sections stored for days or weeks lose reactivity and 
background often increases. 
4. All in situ reagents were prepared on ice and 
used at the indicated temperatures [46, 74, 87]. 
5. Oligonucleotides were synthesized on an Applied 
Biosystems, Inc. (Forest City, CA) Model 380B or 394A 
according to the {3-cyanoethyl phosphoramidite chemistry 
method [12}. The newly synthesized oligo-nucleotides 
were purified by reverse phase high pressure liquid 
chromatography on a 4. 6 x 250 mm Cl 8 column (Rainin 
Instrument Co., Woburn, MA) The column was equili-
brated with 0.02 M triethylammonium acetate, pH 7.0; 
and the elution was accomplished by a linear grad-ient 
of 5% to 30% acetonitrile in 12 min. This typically 
yields 100 pMl!,'l of 25-nt oligonucleotides [19]. 
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6. Preparation of in situ Hybridization (/SH) 
Solutions for step #3: A minimum of 20 µ,l of final /SH 
working solution containing the oligoprimers is needed 
for each slide. The following stock and final working 
solutions are recommended: 
Solution HJ 
Formulation Volumes Final Concentration 
Deionized Formamide 500 µ,l 
20xSSC 200 µ,l 
J0mg/10 ml BSA 200 µ,l 
38.5mg/5 ml DIT 100 µ,l 






Take 160 µ,l of solution #1 and add 2.5 µ,l of 40Ulµ,l 
RNase Inhibitor (Boehringer Biochemica, 
Mannheim, FRG) to give a total of JOOU in 162.5 
µ,l. (Enough for 8 slides) [8-11]. 
Solution HJ 
Final working solutions: Makes 44 µ,l to 46 µ,l of 
/SH mixture containing Oligonucleotide. Enough 
for 2 slides when used at 20 µ,I/slide. Adjust volume 
for additional slides. 
7. Preparation of in situ Transcription (1ST) Solu-
tion: Prepare solution with cold reagents and hold on 
ice until used. 15 µ,l of final working 1ST solution is 
needed for each slide. 
Solution HJ 
Formulation 


















Solution H2: Final Working Solution: 
Solution HJ 140.0 µ,l 
BM" Digoxigenin-
D NA Labeling Mix (J0X) 15.0 µ,l 0.lmM/base 
BM RNase Inhibitor 
(40Ulµ,l) 2.5 µ,l JOOU/163.5µ,l 
BM AMV Reverse Transcriptase 
(24Ulµ,l) 6.0 µ,l 150U/163.5µ,l 
37 
Total 163.5 µ,l 
* = Boehringer Mannheim Biochemica [13, 21, 33, 41, 
84, 94]. 
8. In negative control slides the procedure was 
modified by: a) omitting the /SH Oligonucleotide step 
#3, b) omitting the DIG-DNA Labeling Mixture from 1ST 
step #6, c) omitting the AMV Reverse Transcriptasejrom 
!ST step #6, or d) a combination of these omissions. 
9. ln the immunocytochemical detection of 
Digoxigenin all immunoreagents were diluted with 1 % 
BSA in 0.05 M Tris buffer saline (TBS) pH 7.4 [60, 87, 
95]. 
IO. Preparation of Silver Enhancement Solutions: 
In the silver enhancement step, a 100 ml final working 
solution is prepared as follows: 
Formulation 
Solution HJ: 
Citric Acid, monohydrate 
Sodium Citrate, dihydrate 
Distilled Hp 














2.55 g 120mM 




0.85 g 77mM 
15 ml 
15 ml 
0.11 g 5.5mM 
15 ml 
15 ml 
Final Working Solution: First mix solutions #1 and H2, 
just before use add solution #3. The final working 
solution should be kept in the dark as much as possible, 
i.e. , wrap working solution container and staining jars 
with aluminum foil. 
Recommended protocols of in situ PCR 
The published protocols for in situ PCR and in situ 
RT PCR are very different. Here we presented the 
protocols for detecting HIV RNA and DNA as an 
example to illustrate the techniques [96]. HIV ISPCR 
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and HIV RT-ISPCR protocols take an average of three 
full working days and follow the same guidelines of 
other ISPCR methods. The same kits are used as for 
conventional PCR and RT-PCR. The technician's 
schedule must be planned in advance. An ISPCR 
laboratory should have a full-time and motivated staff. 
Common materials and equipment. The equip-
ment and reagents needed are identical to those for in 
situ hybridization plus reagents, enzymes and probes 
specified in the protocols. An in situ PCR machine is 
also required. For our purposes, we employed the in 
situ PCR Machine (PTC-100-16MS) for MJ Research 
Inc. (Watertown, MA). Other in situ PCR machines 
designed for slides can also be used. 
Protocol #4: In situ polymerase chain reaction 
using HIV biotinylated probe on tissue sections. 
1. Deparaffined tissue sections or cytological 
samples are digested with 30 µglmL of proteinase K 
solution, inside a humid chamber at 37°C for 15 to 30 
rmn. 
2. Wash sections in double-distilled (dd) HP for 10 
min twice. 
3. Place slides on a block at 70-75°C for 1 min to 
inactivate the enzyme, followed by washing. 
4. Prehybridize the sections inside a humid chamber 
at 42°C for 30 min using 50 µL of a solution composed 
of 12 % dextran sulfate , 2x SSC, 0.12 mM EDT A and 
0.33 mg/mL salmon sperm DNA. 
5. Remove the excess prehybridization solution from 
each section and heat each of them to 75°C in a slide 
thermocycler (MJ Research). 




lOx PCR Buffer II 
25 mM MgCl 2 
10 mM each dNTP 
25 mM each primer 
(SK38/39 or SK102/432) 





5 µL Ix 
5 µL 2.5 mM 
1 µL 200 µM each 
1 µL 0.5 mM each 
0.25 µL 1.25 U/50 µL 
7. Cover each section with a glass coverslip one at 
a time and completely seal the edges with an appropriate 
amount of transparent nail polish. Keep all the slides at 
75°C until the PCR mixture has been added to the last 
one. 
8. Start the thermocycling. The temperature 
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parameters for ISPCR are 95°C 1.5 min (initial denatur-
ing), 30 cycles of95°C (denaturing) 30 s, 55°C (anneal-
ing) 45 s, and 72°C (extension) 30 s. This is followed 
by 72 °C (final extension) 1.5 min, and storage at 4 °C 
(soaking). 
9. The nail polish is softened with acetone and the 
cover slips are carefully removed with a surgical blade. 
Immediately, the sections are washed in 5x SSC, 2x 
SSC and PBS for 5 min each. 
10. Bake the sections in an oven at 60°C for 20 
mm. 
11. One hundred microliters of hybridization 
solution are added to each section. Heat to 95°C, 5 min 
for denaturing. Avoid evaporation of the solution. 
Hybridize overnight in a humid chamber at 45°C. 
Hybridization Solution 
50 % formamide 
25 % dextran sulfate 
2x SSC 
0.33 mg/mL salmon sperm DNA 
HIV-1 biotinylated probe (SK19 or SK102 for 
SK38/39 and SK145/43 l amplifications, respec-
tively) at 250 to 400 pg/mL concentration. 
12. Wash the sections with 5x SSC, 2x SSC and 
PBS for 5 min each. 
13. Detection is performed using a kit for bio-
tinylated probes (K600: DAKO, Carpenteria, CA) based 
on the linkage of streptavidin and biotinylated alkaline-
phosphatase coupled to NBT/BCIP calorimetric reaction 
(blue color). 
14. Once the detection is completed, wash the 
section in PBS for 5 min. If desired, slides may be 
slightly counter stained with Pyronin-Y, Nuclear Fast 
Red or Fast Green. These dyes should be dissolved in 
2x SSC or PBS and not in ddHp. 
15. Dry sections at 50°C in an oven and cover 
using permanent mounting media. 
Notes to protocol # 4. 
1. In step # 1, the digestion time and temperature 
vary according to type of specimen and must be empiri-
cally verified. 
2. In step # 7, avoid excessive nail polish; other-
wise, slides will not fit into the companments of the 
thermocycler. Use the pipet tip to adjust the cover slips. 
Bubbles trapped beneath the coverslip will usually come 
out by themselves during heating. Therefore, do not try 
to remove them by pressing the coverslip. 
3. In step # 13, this reaction is carried out in dark-
ness and monitored at about 15-min intervals under a 
light microscope, usually for no more than 1 h. 
In situ hybridization, transcription, and PCR 
Protocol #5. Reverse transcriptase-in situ PCR 
on tissue sections. Method A. Reverse transcriptase-
driven RT-ISPCR. 
1. Deparaffined tissue sections or cytological 
specimens are digested with 30 µg/mL proteinase K 
solution inside a humid chamber at 30°C for 15 to 30 
min. Digestion process may be varied (see above). 
2. Sections are washed twice in ddHp for 10 min 
and heated to 70-75°C for 1 min to inactivate the 
enzyme. 
3. Sections are pretreated with RNase-free DNase. 
Ten to twenty U/section incubating at 37°C for a 
minimum of 4 h. Overnight incubation is strongly ad-
vised to completely destroy the DNA. 
4. The sections are extensively washed with several 
changes of ddH20 for 20 min. 
5. Ten microliters of RT mixture (GeneAmp RNA 
PCR Kit) are added to each section and incubated inside 




MgCl 2 2.0 µL 5mM 
lOx Buffer II 1.0 µL lx 
ddH20 1.5 µL 
dNTPs each 1.0 µL 1 mM 
RNase inhibitor 0.5 µL 1 U/10 µL 
Reverse transcriptase 0.5 µL 2.5 U/10 µL 
Random hexamers 0.5 µL 2.5 µM 
Total volume 10.0 µL 
6. Sections are incubated in a humid chamber at 
42°c for 20 min. 
7. Twenty microliters of prehybridization solution 
(same as used for HIV ISPCR) are added to each 
section. 
8. Slides are placed in the slide thermocycler (MJ 
Research) set with one cycle above 95°C for 3 min (to 
inactivate the reverse transcriptase) and 5°C for 5 min. 
9. Sections are incubated with the residual pre-
hybridization solution in a humid chamber at 42°C for 
20 min. 


















0.25 µL 1.25 U/50 µL 
0.5 µL 0.25 µM 
0.5 µL 0.25 µM 
40 µL 
11. The amplification is performed in the slide ther-
mocycler using the same parameters as for HIV ISPCR 
(see above). 
12. Hybridization and detection are also performed 
as described in HIV ISPCR. 
Method B. rTth DNA polymerase-driven RT-
ISPCR 
1. Deparaffined tissue sections or cytological 
specimens are digested with 30µg/mL proteinase K 
solution inside a humid chamber at 37°C for 15 or 30 
rmn. 
2. Sections are washed twice in ddH20 for 10 min 
and heated to 70-75°C for 1 min to inactivate enzyme. 
3. RNase-free DNase pretreatment is performed as 
described above. 
4. Sections are extensively washed in ddHp for 20 
mm. 
5. Twenty microliters of RT mixture (Thermostable 
rTth Reverse Transcriptase RNA PCR Kit; Perkin-
Elmer) are added to each section and incubated inside a 




ddH20 11.5 µL 
lOx RT Buffer 2.0 µL lx 
MnCl 2 2.0 µL 1 mM 
dNTPs each 0.4 µL 200 µM 
rTth DNA polymerase 2.0 µL 5 U/20 µL 
"Downstream" 
primer SK39 1.0 µL 0.75 µM 
Total volume 20.0 µL 
6. Next the humid chambers containing the slides 
are placed in a refrigerator at 4 °C to stop the reaction. 
7. Ten microliters of 12 % dextran sulfate solution 
containing 1 mg of glycogen are added to each section. 





L.E. De Bault and J. Gu 
ddH 20 61.0 µ.L 
lOx Chelating buffer 8.0 µ.L 0.8x 
MgC12 10.0 µ.L 2.5 mM 
"Upstream" 
primer SK38 1.0 µ.L 0.25 µM 
Total volume 80.0 µ.L 
9. Amplification is performed in the slide 
thermocycler (MJ Research) using the same parameters 
as for HIV ISPCR (see above). 
10. Hybridization and detection are also performed 
as described for HIV ISPCR. 
Notes to Protocol #5. 
J. Radioisotope or digoxigenin-labeled in situ 
hybridization could be more sensitive than biotin-labeled 
in situ hybridization. 
2. The probe in the hybridization solution (step 8) 
can be heated to 95 °C for 5 min before being applied to 
the tissue section to eliminate any self-annealing or 
secondary-structure formation by the probes. 
3. Up to step JO, procedure should be performed in 
an RNase-free manner. 
4. The hybridization mixture can be applied to 
dehydrated dry sections or to wet sections. If the latter, 
there should be as little liquid remaining on the slides as 
possible to avoid disbursing concentrations of the 
ingredients in the hybridization solution. 
5. For a hybridization solution of less than 40 µl per 
tissue section, a coverslip can be applied and sealed at 
the hybridization step (step 9) to prevent evaporation. 
6. RNase may be used in posthybridization treatment 
to remove single-stranded probes, thereby reducing the 
background. The RNase can be applied at JOO µg of 
RNase A per ml and J U of RNase Ti per µl for 30 min 
at 37°C. 
7. Counterstain should not mask or overshadow the 
specific labeling. 
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Discussion with Reviewers 
Reviewer I: Among different fixatives which one would 
you prefer for expression analyses of a particular gene 
in the tissue sections? 
Authors: 10 % formalin or 4 % paraformaldehyde in 
0.01 M PBS adjusted to pH 7.4. 
Reviewer I: Would it be possible to amplify a particular 
genetic element from a tissue section which has been 
fixed in paraformaldehyde or formalin for longer period 
of time like 5-10 years? 
Authors: It is possible to amplify targets in formalin or 
paraformaldehyde fixed archive tissue samples. One 
example was reported by Isaacson et al. (1994) who 
examined polio, measles, influenza and HTL V-1 in 
archival brain tissue samples with in situ RT-PCR and 
detected their RNA sequences in individual neurons, glia 
and vascular endothelial cells. Some of the paraffin 
tissue blocks were over 25 years old. However, it 
should be pointed out that the degree of success with 
archival material is dependent on the completeness of the 
fixation and the nature of the target sequence. 
Reviewer I: You mentioned that the concentration of 
probes in the range of 200-1500 ng/ml depended on the 
size of the probe. How does the size of the probe relate 
to concentration, is it empirical or certain defined rules 
that govern the concentration and size of the probe? 
Authors: The concentration in this case was given in 
ng/ml. At a given concentration, the larger the probe, 
the fewer the number probes available per ml of solu-
tion. Thus, the concentration should be increased 
proportionally with the increase in probe length to 
ensure that a sufficient number of probes are available 
for hybridization. 
Reviewer II: The authors state that single stranded (ss) 
DNA probes are superior to double stranded (ds) DNA 
probes because they do not self-anneal. The hybridiza-
tion signal's intensity ultimately reflects the number of 
reporter nucleotides on the probe-target complex. For 
a target of 8,000 base pairs (a small virus), a ds probe 
can easily be made that covers this entire region; this is 
much more difficult with the ss DNA probe. In my 
experience ds DNA probes usually give the best results; 
this is most notable with the ultimate small single 
stranded DNA probe, i.e, the oligoprobe. Do the 
authors have any direct experience showing that a ss 
DNA probe is superior to a ds DNA probe and, if so, 
would this be expected for large targets ( > 1000b )? 
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Authors: This depends on the size of the probe and the 
target and how the probes are labeled. When the single 
stranded and double stranded probes are the same size 
and identically labeled, single stranded probes are more 
efficient as they do not normally anneal to themselves. 
In the case of a large target where large single stranded 
probes are difficult to make, double stranded probes will 
be superior. On the other hand, longer probes will find 
less targets than shorter ones, thereby having decreased 
detecting sensitivity but giving a more specific signal. 
Reviewer II: In the section on trouble-shooting for in 
situ hybridization, the authors state that probe design is 
a very important factor. In my experience, nick transla-
tion and random primer usually give good results for 
probe synthesis for any DNA template of > 500 hp. 
Define probe design and explain its role in troubleshoot-
ing. In the case of no signal with in situ hybridization, 
I would recommend that the investigator use his/her 
labeling system and an alu DNA probe tern-plate, as the 
repetitive alu sequence is present as thousands of copies 
in mammalian cells. Do the authors agree with this 
strategy or do they recommend some other method to 
deter-mine the cause of a lack of signal with in situ 
hybridization that involves changing probe design? 
Authors: Probe design in this context refers to the 
selection of a particular fragment of the sequence 
complementary to the target and the length of this 
sequence, rather than the way the probes are labeled. In 
our experience, when experimenting with a new target, 
repeated negative signals, even after modifying the 
hybridization conditions, call for a new probe to a 
different portion of the target. Certain probes work well 
and others do not, i.e., either too faint a signal or too 
much a background, even if, in theory, the new probe 
should work equally well. This may have to do with the 
degree of the uniqueness of the probe sequence and the 
way the target sequences are folded and embedded in the 
tissue sample, presenting different availability of the 
target sequences to the particular probes selected. The 
suggested alu DNA probe ternplet approach is a good 
method to check the labeling efficiency, the general 
hybridization conditions and target (alu sequences) 
availability, but give little indication to the suitability of 
the particular probe that gives weak or no signal. In 
addition to employing the alu sequence, shifting the 
target sequence or using a collection of different se-
quences to different or overlapping portions of the target 
should be tested. By changing the probe design, i.e., to 
use a different probe sequence, we have solved the 
problems of false negative hybridization in a number 
cases while other modifications produced little success. 
M. Malecki: Do you perform liquid phase PCR as a 
In situ hybridization, transcription, and PCR 
way to optimize annealing temperature for a specific 
target? 
Reviewer I: Besides the critical parameters like Protein-
ase K, probes, and primers, do you think optimization 
of annealing temperature is also critical, and if it is so, 
how can one proceed with optimization of the system? 
Authors: Optimization of annealing temperature is also 
very important, of course. This can be established by 
keeping the other factors constant and testing a number 
of temperature settings. It can also be established by 
liquid phase PCR with the same target and primers. 
Nevertheless, the temperature should not vary too much 
from target to target. 
Reviewer II: Background signals with in situ hybridiza-
tion are due to nonspecific sticking of the labeled probe 
to cellular proteins and/or nucleic acids. That is, the 
probe, which presumably enters all cells, will diffuse out 
unless it finds its complementary target or non-specifi-
cally sticks to cellular components. From a practical 
viewpoint, I would argue that the most likely causes of 
background are: a) posthybridization wash not stringent 
enough, where temperature is a key factor; b) probe 
concentration too high. The questions are: 1) why do 
the protocols not include a temperature for the post 
hybridization wash. 2) Most protocols do not include a 
prehybridization wash, which, in my experience, does 
not affect background. Have the authors done compara-
tive studies of background with and without prehybridi-
zation? 
Authors: Background signals with in situ hybridization 
are caused by nonspecific or less specific sticking of the 
labeled probes to cellular proteins and/or nucleic acids 
or may be trapped by cytoskeleton structures that in 
theory can be removed by critical washing. Tempe-
rature, stringency of the washing solution, washing 
duration and vigilance are all factors affecting the 
efficiency of probe removal from the tissue sample. 
Temperature is one of the factors that affect the outcome 
significantly. We usually raise the temperature up to 
50°C if the initial washing does not remove most of the 
background staining. The optimal condition should be 
established empirically for each case, therefore no 
particular temperature is recommended. We have per-
formed comparisons between protocols with and without 
prehybridization washes and found that prehybridization 
washing reduced background staining is some cases, 
presumably by blocking potential nonspecific bonding 
sites in the tissue sample. We also know that this 
prehybridization washing does not affect the efficacy of 
amplification nor does it increase background staining. 
We routinely perform prehybridization washing for both 
in situ hybridization and in situ PCR. 
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Reviewer II: With 1ST, one is making labeled cDNA 
inside the cell. Do the authors know of instances where 
this labeled product diffused out of the cell and into 
another cell type known to not have the target? 
Authors: We know of no published case where the 
labeled cDNA product of 1ST diffused into another cell 
type not containing the target sequence. In 1ST, the 
cDNA is literally synthesized on the target sequence 
creating a double stranded nucleic acid duplex with little 
or no mismatched NTP pairs. Such double stranded 
duplexes are very stable and require strong denaturing 
conditions to separate the new cDNA from its comple-
mentary strand, i.e., high melting temperatures well in 
excess of the 45°C used in the last 10 min of the 
transcription step, high stringency conditions in excess 
of 2xSSC at room temperature plus 0.05xSSC at 35°C. 
Reviewer II: The authors state that extensive washing of 
the protease and DNAse is needed with in situ PCR. 
However, in my experience, a 1 minute wash in water 
and a 1 minute wash in 100 % ethanol is enough to 
eliminate these enzymes. Have the authors demonstrated 
any change in the in situ PCR signal relative to the 
length of wash after one or both of these enzymes? 
Authors: You may be right, but we prefer to be on the 
safe side. When there are so many steps that can go 
wrong we want to be sure that the experiments are not 
ruined by easily avoidable mishaps at the beginning of 
the protocol. We also know that extensive washing does 
no harm to the targets and subsequent reactions. 
Reviewer Il: The authors claim that one can make 
millions of copies of the amplicon in the cell during in 
situ PCR. However, most investigators report a 200+ 
fold increase in copy number, and not a million fold 
increase. It would, on a theoretical basis, seem unlikely 
that one could amplify one million copies in a space of 
10µ, given the extremely high concomitant amplicon 
concentration which is one of the limits on the extent of 
amplification in a 100µ1 reaction volume. What is the 
basis for the authors claim for such a marked increase in 
copy number during in situ PCR? 
Authors: It is true that PCR on tissue sections or intact 
cells is not as efficient as liquid phase PCR due to the 
limited accessibility of the target and the interference of 
fixed tissue structures as well as the smaller amount of 
solution (we add about 50-100 µI of PCR solution to the 
slide depending on the size of the sample). But once a 
sequence is amplified, more than a few hundred copies 
will result within the next ten cycles. Nobody knows, 
even roughly, how many copies of amplicons there are 
after amplification in situ. It is difficult, if not impossi-
ble, to measure. By theory, the amplicons are free 
floating and they diffuse out freely following each cycle 
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of amplification, therefore leaving rooms for new 
amplicons to form. We believe that the estimated 200 
plus copies of the amplicons by others are not grounded. 
One thing appears to be true, i.e, there are not too many 
copies left in situ by the time the signals are examined 
under the microscope. Judging by the intensity and the 
size of the reporting signal, there should not be more 
than a few hundred copies of the ampli-cons remaining 
in their original location. Nevertheless, this does not 
mean that only those amplicons are produced by the 
PCR, as most of them have diffused or been washed 
away. There is no reasonable mechanism to keep the 
amplicons remaining in situ, except the possible long 
amplicon theory proposed by one of the authors (JG) and 
some possible trapping and network-forming pheno-
menon to hold the amplicons on site. We speculate that 
most amplicons diffuse to the supernatant easily. 
Reviewer II: The authors state that back diffusion is a 
formidable problem with in situ PCR. Back diffusion 
would presumably be due to the large amount of labeled 
amplicon in the overlying solution sticking to cellular 
proteins and/or nucleic acids. This is equivalent to 
every in situ hybridization reaction, where one has a 
large amount of labeled DNA that can stick non-specifi-
cally to cellular components. This can be removed by 
a high stringent wash, owing to the weak force of these 
bonds versus the much stronger hydrogen bonds with 
100% homology between probe and target. Explain why 
back diffusion (background) is any more of an issue with 
in situ PCR versus in situ hybridization. 
Authors: The answer to this question is related to the 
issue discussed in a previous question ("In the section on 
troubleshooting ... "). In the situation of in situ PCR, 
the concentrations of the amplicons are much higher than 
that used for in situ hybridization, and increasingly so 
until a plateau is reached. This large amount of ampli-
cons will diffuse to other parts of the tissue sample and 
may stick to them, semi-specifically or non-specifically 
by bonding to proteins, or simply be trapped and tangled 
at nonspecific sites. In addition, the variations in sizes 
of the amplicons may "stick" to non-specific sites more 
easily than the more uniformly sized probes in the 
solution of in situ hybridization. More-over, the tissue 
samples for in situ PCR tend to be more harshly treated 
than those used in straight in situ hybridization. For 
these reasons, the so-called back diffusion may be more 
readily seen during in situ PCR than during in situ 
hybridization. It should also be noted that back diffu-
sion does not occur only with labeled amplicons, but 
unlabeled amplicons produced in the so-called indirect in 
situ PCR protocol can also cause nonspecific sticking 
and subsequently be picked up by hybridization step 
used in the detection process resulting in nonspecific staining. 
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Reviewer I: Between the two in situ PCR strate-gies, 
i.e., direct incorporation of labeled molecules into 
amplified products or indirect labeling like addition of 
labeled probe, which one is better and why? Would you 
please comment on this? 
Authors: We prefer the indirect methods, as do most 
investigators. It has an added step to check the specific-
ity. Since some nonspecific sequences are amplified in 
PCR, they will not be picked up by the specific probes 
in the hybridization step used in the detection system. 
It should also be pointed out that in the indirect method, 
nonspecific DNA repair, etc. will not affect the final 
results. This has been discussed extensively in a number 
of publications. 
Reviewer II: An important measure of specificity with 
ISH, 1ST, or in situ PCR is afforded by knowing which 
cell type likely contains the target of interest. There is 
often striking localization of the target to specific cell 
types. An example would be parvoviral infections 
where the target (the nucleated red blood cell) is easily 
identified on morphologic grounds. According to 
published reports, with in situ hybridization and reverse 
transcriptase (RT) in situ PCR, the signal only localizes 
to the target cell, assuming a high stringent wash. If the 
wash is not stringent enough, then other cell types show 
signals with both methods. Explain why background 
should be any more of a problem with in situ PCR 
versus in situ hybridization, where an excess of probe 
far greater than can be synthesized during the cycling 
process is present, and why it is not evident in many 
published reports of viral infection and in situ PCR 
where the target cell is known? 
Authors: This question has been partially answered in 
a previous question ("The authors state that back diffu-
sion .... "). To start with, in situ PCR is usually em-
ployed only after the conventional in situ hybridization 
failed to detect any signal convin-cingly. The extremely 
high detecting sensitivity of in situ PCR leads the 
investigators to a new territory where more marginal 
positivity may be present and positive signals may show 
up in unexpected cell types. When those occur, exten-
sive controls are called for and the new results may still 
not be black and white. These all make the interpreta-
tion of the in situ PCR and, in particular, RT in situ 
PCR results more difficult. For target mRNA, it is 
often a matter of difference in quantity among different 
cell types rather than a yes or no answer. We speculate 
that when the target locations are known, the authors are 
more confident to publish their results and the articles 
are more likely to be accepted by journal referees. The 
many, less than clear cut observations, even though they 
may be closer to the truth, were buried in the lab's 
notebooks and data bases. 
In situ hybridization, transcription, and PCR 
M. Malecki: Would you be able to estimate the dis-
tances between the target sequences and the reporter 
molecules in ISH, 1ST, and ISPCR? 
Reviewer III: Could you analyze differences in the 
distribution of reporter molecules around the target 
sequence labeled by 1ST and ISPCR as compared to 
ISH? 
Authors: The distances between target sequences and 
reporter molecules in different methods depend on many 
factors, including the size of the probes, the size of the 
target, the type of tissue, the labeling methods, the 
signal detecting methods, the visualization approach, etc. 
It all depends on how much the targets have been 
amplified and retained and what projection range the 
reporter signal build-up has achieved by the particular 
detecting method. It can range from the immediate 
proximity as in 1ST, to a signal that can engulf the entire 
cell by one target sequence in IS PCR. In general, in 
situ hybridization gives more localized signals than the 
other two techniques. 
Reviewer I: In the HIV ISPCR protocol, prehybri-
dization is recommended before doing actual ISPCR. 
Does it provide certain (extra) advantage(s) for in situ 
PCR amplification? 
Authors: We routinely perform prehybridization for in 
situ hybridization and find this step reducing background 
labeling. For indirect in situ PCR, prehybridization is 
also necessary. We perform this step before the PCR 
cycles rather than afterwards, i.e., directly before the 
subsequent in situ hybridization. This way, we avoided 
the prehybridization step between the PCR cycles and 
the hybridization step and believe that this is beneficial 
for preventing diffusion of or washing away the ampli-
cons from their original sites. 
Reviewer I: In the HIV ISPCR protocol, in step #9 
acetone is recommended for softening of nail polish. 
Most people use absolute ethanol for this purpose. Do 
you think acetone is better over ethanol? 
Authors: It is our preference. Both will work. We 
have not made a systematic comparison. 
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